Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: Evaluation by selective depletion of low-density lipoproteins or fibrinogen

Metabolism: Clinical and Experimental

Volumn 49, Issue 6, 2000, Pages 810-813

  Otto, C ^a   Richter, W O ^a   Schwandt, P ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MICROCIRCULATION; PLASMA VISCOSITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034046332     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.6264     Document Type: Article

References (18)

1. Kannel WB Castelli WP Gordon T Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham Study Ann Intern Med 90 1979 85 91
2. Koenig W Sund M Ernst E Association between rheology and components of lipoproteins in human blood. Results from the MONICA Project Circulation 85 1992 2197 2204
3. Moller L Kristensen TS Plasma fibrinogen and ischemic heart disease risk factors Arterioscler Thromb 11 1991 344 350
4. Stefanick ML Legault C Tracy RP Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study Arterioscler Thromb Vasc Biol 15 1995 2085 2093
5. Barasch E Benderly M Graff E Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study J Clin Epidemiol 48 1995 757 765
6. Lowe GDO Blood viscosity, lipoproteins, and cardiovascular risk Circulation 85 1992 2329 2331
7. Yarnell JWG Baker IA Sweetnam PM Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies Circulation 83 1991 836 844
8. Lowe GDO Wood DA Douglas JT Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina Thromb Haemost 65 1991 339 343
9. Leonhardt H Arntz HR Klemens UH Studies of plasma viscosity in primary hyperlipoproteinemia Atherosclerosis 28 1977 29 40
10. Seplowitz AH Chien S Smith FR Effects of lipoproteins on plasma viscosity Atherosclerosis 38 1981 89 95
11. Laudano AP Doolittle RF Studies on synthetic peptides that bind to fibrinogen and fibrin polymerization. Structural requirements, number of binding sites, and species differences Biochemistry 19 1980 1013 1019
12. Kuyas C Haeberli A Walder P Isolation of human fibrinogen and its derivates by affinity chromatography on Gly-Pro-Arg-Pro-Lys-Fractogel Thromb Haemost 63 1990 439 444
13. Stoffel W Greve V Borberg H Application of specific extracorporeal removal of low-density lipoprotein in familial hypercholesterolemia Lancet 2 1981 1005 1007
14. Lowe GDO Blood viscosity and cardiovascular disease Thromb Haemost 67 1992 494 498
15. Lee AJ Smith WCS Lowe GDO Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study J Clin Epidemiol 43 1990 913 919
16. Eliasson M Evrin PE Lundblad D Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study J Clin Epidemiol 47 1994 513 524
17. Otto C Pschierer V Soennichsen AC Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia Metabolism 46 1997 1299 1304
18. Stein JH Rosenson RS Treatment of severe hypertriglyceridemia lowers plasma viscosity Atherosclerosis 137 1998 401 405